ACL Reconstruction: Clinical Outcome
RIC-ACL
Anterior Cruciate Ligament Reconstruction: Clinical Outcome at Middle and Long Term Follow-Up
1 other identifier
observational
1,000
1 country
1
Brief Summary
The study is intended to include all patients who will undergo surgical reconstruction of the anterior cruciate ligament (ACL). The patients will be monitored and evaluated preoperatively and also at 6 months and 1, 2 and 5 years after the intervention through a clinical visit or telephone interview. Such assessments will include the administration of questionnaires to determine the patient's functional symptoms and the objective examination of the knee during a medical examination to quantify its stability.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 29, 2017
CompletedFirst Posted
Study publicly available on registry
February 22, 2018
CompletedStudy Start
First participant enrolled
December 17, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2030
February 2, 2026
June 1, 2025
10 years
August 29, 2017
January 29, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Knee Laxity Assessment
Laxity Evaluation with KiRA device
5 years
Secondary Outcomes (5)
SF12 Score
5 years
Marx Activity Rating Score
5 years
KOOS Score
5 years
IKDC Score
5 years
VAS Score
5 years
Interventions
Surgical ACL reconstruction
Eligibility Criteria
Patients with ACL lesions and undergoing to surgical ACL reconstruction
You may qualify if:
- Patients who have provided informed written written consent;
- Patients aged between 18 and 60;
- Patients undergoing reconstructive surgical treatment of the anterior cruciate ligament (ACL)
You may not qualify if:
- Patients unable to understand and to want;
- Patients who have not signed informed consent;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stefano Zaffagnini
Bologna, Italia, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Prof
Study Record Dates
First Submitted
August 29, 2017
First Posted
February 22, 2018
Study Start
December 17, 2020
Primary Completion (Estimated)
December 1, 2030
Study Completion (Estimated)
December 1, 2030
Last Updated
February 2, 2026
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share